Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

REVB

Revelation Biosciences Inc

May 08 • 04:00PM ET

0.9600

-0.0600 -5.88 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: NRXP SABS TNXP BLRX BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-39.47	Insider Own	4.94%	Shs Outstand	3.91M	Perf Week	-14.29%
Market Cap	3.75M	Forward P/E	-	EPS next Y	-3.62	Insider Trans	0.00%	Shs Float	3.41M	Perf Month	-21.95%
Enterprise Value	-9.60M	PEG	-	EPS next Q	-2.13	Inst Own	8.38%	Short Float	0.66%	Perf Quarter	-41.82%
Income	-21.50M	P/S	-	EPS this Y	78.12%	Inst Trans	6.87%	Short Ratio	0.24	Perf Half Y	-77.78%
Sales	0.00M	P/B	0.29	EPS next Y	31.01%	ROA	-103.83%	Short Interest	0.02M	Perf YTD	-69.99%
Book/sh	3.32	P/C	0.27	EPS next 5Y	-	ROE	-124.41%	52W High	40.08 -97.60%	Perf Year	-97.42%
Cash/sh	3.61	P/FCF	-	EPS past 3/5Y	94.09% 76.86%	ROIC	-72.44%	52W Low	0.99 -3.04%	Perf 3Y	-99.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.33% 6.28%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	96.30%	Oper. Margin	-	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.02	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	25.09	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.02	EPS Q/Q	89.31%	SMA20	-15.29%	Beta	-0.13	Target Price	19.25
Payout	-	Debt/Eq	0.06	Sales Q/Q	-	SMA50	-19.12%	Rel Volume	2.37	Prev Close	1.02
Employees	8	LT Debt/Eq	0.05	Earnings	Feb 26 AMC	SMA200	-78.02%	Avg Volume	93.87K	Price	0.96
IPO	Nov 17, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	54.92% -	Trades		Volume	222,913	Change	-5.88%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)